Intracerebral hemorrhage is a neurovascular emergency associated with high mortality and morbidity. With in-depth reviews of the clinical and biological aspects of the condition, this text provides an up-to-date coverage of this form of stroke. The book covers epidemiology, causes, clinical presentation, management and prognosis, and describes the ongoing research advances aimed at improving our understanding of the condition. The book fills an existing gap in the medical literature. The chapters discussing the clinical aspects of intracerebral hemorrhage are aimed at the practitioner directing the care of stroke victims. Chapters exploring the biology of pathophysiological events triggered by this disease will provide readers with current data directed to facilitate experimental research in this field of cerebrovascular neurology. It will appeal to clinicians and those with a research interest in cerebrovascular diseases.do not state the dose of FCC . ... Concerning the latter both recommendations mention PCC and FFP, while the AHA is also considering factor IX ... point that factor concentrates may act faster but may have an increased thromboembolic risk, while FFP is associated with ... Consequently, the efficacy of FFP in controlling bleeding is unpredicta able and it may not fully reverse an increased INR [38, 67].
|Author||:||J. Ricardo Carhuapoma, Stephan A. Mayer, Daniel F. Hanley|
|Publisher||:||Cambridge University Press - 2009-11-12|